Cargando…
Pregabalin Add-On vs. Dose Increase in Levetiracetam Add-On Treatment: A Real-Life Trial in Dogs With Drug-Resistant Epilepsy
Epilepsy is a common neurological disorder affecting 0.6–0.75% of dogs in veterinary practice. Treatment is frequently complicated by the occurrence of drug-resistant epilepsy and cluster seizures in dogs with idiopathic epilepsy. Only few studies are available to guide treatment choices beyond lice...
Autores principales: | Kriechbaumer, Sandra R. P., Jurina, Konrad, Wielaender, Franziska, Schenk, Henning C., Steinberg, Tanja A., Reese, Sven, Buhmann, Gesine, Doerfelt, Stefanie, Potschka, Heidrun, Fischer, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298511/ https://www.ncbi.nlm.nih.gov/pubmed/35873699 http://dx.doi.org/10.3389/fvets.2022.910038 |
Ejemplares similares
-
Cyclooxygenase-2 Inhibition as an Add-On Strategy in Drug Resistant Epilepsy—A Canine Translational Study
por: Fischer, Andrea, et al.
Publicado: (2022) -
Economic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea
por: Suh, Guk-Hee, et al.
Publicado: (2009) -
Evaluation of the efficacy and tolerability of levetiracetam as add-on therapy in intractable epilepsy of children
por: Razieh, Razieh, et al.
Publicado: (2022) -
Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy
por: CHONAN, Masashi, et al.
Publicado: (2020) -
Oral Levetiracetam as Add-On Therapy in Refractory Neonatal Seizures
por: MOLLAMOHAMMADI, Mohsen, et al.
Publicado: (2018)